This study aimed to evaluate the relationship between the serum galectin-1 level and the incidence of CIN, and to clarify the predictive role of galectin-1 in renal function decline, in patients with suspected CAD undergoing CAG at a single hospital. The gene discussed is LGALS1; the disease is cervical squamous intraepithelial neoplasia.